Fresenius Kabi USA, LLC recalls Tyenne (tocilizumab-aazg) Injection
FDA Class I
FDA classified this recall as Class I: the most serious kind, meaning there is a reasonable chance the product could cause serious health problems or death.
- Hazard
- Presence of particulate matter:An internal investigation at the firm found the product to contain glass particles.
- Products
-
- Tyenne (tocilizumab-aazg) Injection
- Company
- Fresenius Kabi USA, LLC
- Where it was sold
-
Nationwide in the USA
Nationwide
- Units affected
- 4,643 20mL-vials
- About this recall
- Tyenne (tocilizumab-aazg) Injection, 400 mg/20 mL (20 mg/mL), 20 mL vial, Rx Only, Manufactured by Fresenius Kabi USA, LLC, Lake Zurich, Illinois, 60047, NDC 65219-594-20.